CJ

Chirag Jamanbhai Dadhania

Active Director Director DIN 01713590
DIN 01713590 First appointment Apr 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 2 historical roles
Total affiliations 3 Since Apr 2005
Shareholding value •••• Premium profile

About Chirag Jamanbhai Dadhania

Data last updated:

Chirag Jamanbhai Dadhania is a Director at Hema Remedies Private Limited (since 2015). The companies operate in Pharma. Hema Remedies Private Limited reported revenue of ₹17.40 Cr (FY 2024). Earlier, Chirag Jamanbhai Dadhania was a Whole-Time Director at Mepromax Life Sciences Private Limited (2005–2014) and Director at Skymax Laboratories Limited (2007–2018).

DIN 01713590
Primary Designation Director
Industry Pharma
First Appointment 21 Apr 2005
Oldest Company Age 12 yrs
Largest company Hema Remedies Private Limited · ₹17.40 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hema Remedies Private Limited U24100GJ2014PTC080815
Director16 Mar 20152014₹17.40 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director21 Apr 20052005₹82.29 Cr (FY 2025)Active
Skymax Laboratories Limited U24230GJ1993PLC020662
Director27 Sep 20071993Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Chirag Jamanbhai Dadhania

NameDINCompanyDesignation
Abhilash Ashwinbhai Shah00303120Hema Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hema Remedies Private Limited
Mepromax Life Sciences Private Limited
Skymax Laboratories Limited
Premium access

Shareholding and investment profile for Chirag Jamanbhai Dadhania

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chirag Jamanbhai Dadhania

Chirag Jamanbhai Dadhania currently holds 1 directorship: Hema Remedies Private Limited (Director, since 16 Mar 2015, revenue ₹17.40 Cr (FY 2024)).

Chirag Jamanbhai Dadhania was first appointed on 21 Apr 2005 as Whole-Time Director at Mepromax Life Sciences Private Limited. The most recent appointment on record is 16 Mar 2015 at Hema Remedies Private Limited.

Chirag Jamanbhai Dadhania held 2 earlier board appointments: Mepromax Life Sciences Private Limited (Whole-Time Director, 21 Apr 2005 to 15 Jul 2014); Skymax Laboratories Limited (Director, 27 Sep 2007 to 29 Jun 2018).

The current boards of Chirag Jamanbhai Dadhania's companies include Abhilash Ashwinbhai Shah (Hema Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available